SCHEMBL6606547

SCHEMBL6606547

CC1(C)CCCN(c2ccc(N)cc2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.53
MAPT P10636 7/20 0.53
KMT2A Q03164 5/20 0.53
USP2 O75604 5/20 0.53
GAA P10253 4/20 0.53
HSD17B10 Q99714 4/20 0.53
MEN1 O00255 4/20 0.53
ALOX15 P16050 4/20 0.53
KDM4E B2RXH2 3/20 0.53
HTT P42858 3/20 0.53
L3MBTL1 Q9Y468 3/20 0.53
TP53 P04637 2/20 0.53
NPC1 O15118 1/20 0.53
POLB P06746 1/20 0.53
THRB P10828 1/20 0.53
RECQL P46063 1/20 0.53
RAB9A P51151 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
GFER P55789 4/20 0.47
ADRA2C P18825 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22465998 0.89 MAPT (0.50) ALDH1A1MAPTKMT2AUSP2GAA
SCHEMBL81667 0.84 KMT2A (0.46) ALDH1A1MAPTKMT2AUSP2HSD17B10
SCHEMBL15651141 0.83 ALDH1A1 (0.50) ALDH1A1MAPTKMT2AUSP2GAA
SCHEMBL13723408 0.83 ALDH1A1 (0.50) ALDH1A1MAPTKMT2AUSP2GAA
SCHEMBL17076767 0.83 ALDH1A1 (0.50) ALDH1A1MAPTKMT2AUSP2GAA
SCHEMBL25192659 0.81 MAPT (0.52) ALDH1A1MAPTKMT2AUSP2GAA
SCHEMBL4347686 0.79 ALDH1A1 (0.51) ALDH1A1MAPTKMT2AUSP2HSD17B10
SCHEMBL19000983 0.79 MAPT (0.43) ALDH1A1MAPTKMT2AUSP2HSD17B10
SCHEMBL4631009 0.79 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AUSP2GAA
SCHEMBL12004842 0.79 ALDH1A1 (0.53) ALDH1A1MAPTKMT2AUSP2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1555260-A Aminoalkyl-substituted aromatic bicyclic compounds, process for their preparation and their use as pharmaceuticals ���ĵ�˹ҩ��¹����޹�˾ 2004-12-15 CN disclosed
US-20040198731-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-10-07 US disclosed
US-20040198732-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-10-07 US disclosed
US-20040198733-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-10-07 US disclosed
US-20040192693-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-09-30 US disclosed
EP-1418906-A1 AMINOALKYL-SUBSTITUTED AROMATIC BICYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2004-05-19 EP disclosed
US-20030212070-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-11-13 US disclosed
WO-2003015769-A1 AMINOALKYL-SUBSTITUTED AROMATIC BICYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212070-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC ALDH1A1 404/4885MAPT 3514/4885KMT2A 674/4885
US-20040192693-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC ALDH1A1 404/4885MAPT 3514/4885KMT2A 674/4885
US-20040198731-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC ALDH1A1 404/4885MAPT 3514/4885KMT2A 674/4885
US-20040198733-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC ALDH1A1 404/4885MAPT 3514/4885KMT2A 674/4885
US-20040198732-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC ALDH1A1 404/4885MAPT 3514/4885KMT2A 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.